Medical management of chronic pelvic pain

Review OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This review discusses current medical management strategies for chronic pelvic pain, including pharmacological and non-pharmacological approaches.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Chronic pelvic pain is a symptom of poorly understood aetiology. Pelvic congestion and psychological factors have been identified as important aetiological factors but surprisingly few studies of therapies directed at these aetiologies have been performed. A limited number of trials suggest that the progestagen medroxyprogesterone acetate may be useful in relieving symptoms, but benefit may be restricted to duration of treatment only. Further research is required into both the basis of chronic pelvic pain and its medical management.

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

MeSH descriptors

Pelvic Pain Antidepressive Agents Antidepressive Agents Chronic Disease Dihydroergotamine Dihydroergotamine Female Humans Medroxyprogesterone Acetate Medroxyprogesterone Acetate Pelvic Pain Pelvic Pain Pelvis Pelvis Progesterone Congeners Progesterone Congeners Varicose Veins Varicose Veins Vasoconstrictor Agents Vasoconstrictor Agents

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (33)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:30.381419+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK